id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-P-2322-0004,FDA,FDA-2020-P-2322,Final Response to Covington & Burling LLP from FDA CDER,Other,Agency Response,2022-12-30T05:00:00Z,2022,12,2022-12-30T05:00:00Z,,2022-12-30T18:34:23Z,,0,0,090000648556a0ea
FDA-2020-P-2322-0003,FDA,FDA-2020-P-2322,Interim Response to Covington & Burling LLP from FDA CDER,Other,Response(s),2021-06-24T04:00:00Z,2021,6,2021-06-24T04:00:00Z,,2021-06-24T15:58:10Z,,0,0,0900006484bac316
FDA-2020-P-2322-0002,FDA,FDA-2020-P-2322,Acknowledgment Letter from FDA DMS to Covington & Burling LLP on behalf of Pharmaceutical Research and Manufacturers of America,Other,Acknowledgement Letter/Receipt,2020-12-23T05:00:00Z,2020,12,2020-12-23T05:00:00Z,,2020-12-23T13:43:35Z,,0,0,09000064849bae17
FDA-2020-P-2322-0001,FDA,FDA-2020-P-2322,Citizen Petition from Covington & Burling LLP on behalf of Pharmaceutical Research and Manufacturers of America,Other,Citizen Petition,2020-12-23T05:00:00Z,2020,12,2020-12-23T05:00:00Z,,2024-11-12T23:26:39Z,,1,0,09000064849bae16